Targeting nicotinic receptor antagonists as novel pharmacotherapies for tobacco dependence and relapse.
Dwoskin
Linda P
LP
University of Kentucky National Cooperative Drug Discovery Group, Lexington, KY, USA. ldwoskin@email.uky.edu
Bardo
Michael T
MT
D000818:Animals; D004298:Dopamine / Q000378:metabolism; D016503:Drug Delivery Systems; D006801:Humans; D051379:Mice; D018733:Nicotinic Antagonists / Q000627:therapeutic use*; D010847:Picolines / Q000494:pharmacology; D051381:Rats; D012008:Recurrence; D014029:Tobacco Use Disorder / Q000188:drug therapy*
C513964:N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide; D018733:Nicotinic Antagonists; D010847:Picolines; D004298:Dopamine